Peptide record

TPDB47051

ACE inhibitors derived from yeast GADPH ACE inhibitors Antihypertensive standard
10 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB47051
ACE inhibitors derived from yeast GADPH
ACE inhibitors Antihypertensive
Cardiometabolic peptides
pep-lab Peptipedia AHTPDB AHTpin
standard
No
A 10-aa standard natural multi-activity (ACE inhibitors and Antihypertensive) peptide sequence curated from pep-lab, Peptipedia, AHTPDB, and other sources, with an available 3D structural model.
Sequence
GHKIATFQER
Physicochemical Analysis
C52H83N17O15
NDCLMPSWYV
AREQGHIKFT
1186.34
10.09
3
1
3
+1
3.90
-1.060
49.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
2
Residue Composition
number
1
A
1
R
0
N
0
D
0
C
1
E
1
Q
1
G
1
H
1
I
0
L
1
K
0
M
1
F
0
P
0
S
1
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 0 C: 0 E: 1 Q: 1 G: 1 H: 1 I: 1 L: 0 K: 1 M: 0 F: 1 P: 0 S: 0 T: 1 W: 0 Y: 0 V: 0
Chemical Descriptors
10
C52H83N17O15
1186.34
10.09
+1
3.90
-1.060
1186.3170
1185.6236
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
0.40 µM
ACE inhibitor
ah

Source & Reference

NA
Kohama Y., Nagase Y., Oka H., Nakagawa T., Teramoto T., Murayama N., Tsujibo H.,
Production of angiotensin-converting enzyme inhibitors from baker's yeasts Glyceraldehyde-3-phosphate Dehydrogenase. J. Pharmacobio-Dyn. 13, 766-771
1990
Journal

Other

10
BIOPEP-UWM database of bioactive peptides SMILES: [H][C@](C)(O)[C@]([H])(NC(=O)[C@]([H])(C)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@]([H])(C)CC)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCC(N)=O)C(=O)N[C@@]([H])(CCC(O)=O)C(=O)N[C@@]([H])(CCCNC(N)=N)C(O)=O InChI=1S/C52H83N17O15/c1-5-27(2)41(68-46(78)32(14-9-10-20-53)63-48(80)37(62-39(72)24-54)23-31-25-58-26-60-31)49(81)61-28(3)43(75)69-42(29(4)70)50(82)67-36(22-30-12-7-6-8-13-30)47(79)65-33(16-18-38(55)71)44(76)64-34(17-19-40(73)74)45(77)66-35(51(83)84)15-11-21-59-52(56)57/h6-8,12-13,25-29,32-37,41-42,70H,5,9-11,14-24,53-54H2,1-4H3,(H2,55,71)(H,58,60)(H,61,81)(H,62,72)(H,63,80)(H,64,76)(H,65,79)(H,66,77)(H,67,82)(H,68,78)(H,69,75)(H,73,74)(H,83,84)(H4,56,57,59)/t27-,28-,29+,32-,33-,34-,35-,36-,37-,41-,42-/m0/s1 InChIKey=YWIIIROWEXGMAF-PBEFRTBXSA-N
Evidence 2 Activity

Activity

IC50
Antihypertensive
0.40 µM
ACE inhibitor
ah

Source & Reference

AHTPDB
Kohama Y., Nagase Y., Oka H., Nakagawa T., Teramoto T., Murayama N., Tsujibo H.,
Production of angiotensin-converting enzyme inhibitors from baker's yeasts Glyceraldehyde-3-phosphate Dehydrogenase. J. Pharmacobio-Dyn. 13, 766-771
1990
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
10
BIOPEP-UWM database of bioactive peptides SMILES: [H][C@](C)(O)[C@]([H])(NC(=O)[C@]([H])(C)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@]([H])(C)CC)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCC(N)=O)C(=O)N[C@@]([H])(CCC(O)=O)C(=O)N[C@@]([H])(CCCNC(N)=N)C(O)=O InChI=1S/C52H83N17O15/c1-5-27(2)41(68-46(78)32(14-9-10-20-53)63-48(80)37(62-39(72)24-54)23-31-25-58-26-60-31)49(81)61-28(3)43(75)69-42(29(4)70)50(82)67-36(22-30-12-7-6-8-13-30)47(79)65-33(16-18-38(55)71)44(76)64-34(17-19-40(73)74)45(77)66-35(51(83)84)15-11-21-59-52(56)57/h6-8,12-13,25-29,32-37,41-42,70H,5,9-11,14-24,53-54H2,1-4H3,(H2,55,71)(H,58,60)(H,61,81)(H,62,72)(H,63,80)(H,64,76)(H,65,79)(H,66,77)(H,67,82)(H,68,78)(H,69,75)(H,73,74)(H,83,84)(H4,56,57,59)/t27-,28-,29+,32-,33-,34-,35-,36-,37-,41-,42-/m0/s1 InChIKey=YWIIIROWEXGMAF-PBEFRTBXSA-N
Additional Detail Fields 1 fields
10